These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
114 related articles for article (PubMed ID: 13545890)
1. [General pharmacological properties of a new derivative of phenothiazine with powerful neuroleptic and faint autonomic nervous activity, 10-(3-dimethylamino-2-methylpropyl)-phenothiazine hydrochloride (R.P. 6549)]. COURVOISIER S; DUCROT R; FOURNEL J; JULOU L Arch Int Pharmacodyn Ther; 1958 May; 115(1-2):90-113. PubMed ID: 13545890 [No Abstract] [Full Text] [Related]
2. [General pharmacological properties of a new phenothiazine derivative with powerful antihistaminic and anti-allergic activity, 9,9-dioxo-10-(3-dimethylamino-2-methylpropyl)-phenothiazine (R.P. 6847)]. COURVOISIER S; DUCROT R; JULOU L; LEAU O Arch Int Pharmacodyn Ther; 1962 Feb; 135():364-75. PubMed ID: 13881795 [No Abstract] [Full Text] [Related]
3. Primary steps of the photochemical reactions of 2-cyano-10-(3-[dimethylamino, N-oxide]-2-methylpropyl)-5-oxide-phenothiazine, the photoproduct of cyamemazine, a phototoxic neuroleptic: comparison with the sulfoxide. Bosca F; Morlière P; Miranda MA; Castell JV; Santus R Photochem Photobiol Sci; 2006 Mar; 5(3):336-42. PubMed ID: 16520870 [TBL] [Abstract][Full Text] [Related]
4. Antitumor activity of phenothiazine-related compounds. Nagy S; Argyelan G; Molnár J; Kawase M; Motohashi N Anticancer Res; 1996; 16(4A):1915-8. PubMed ID: 8712720 [TBL] [Abstract][Full Text] [Related]
5. [Study of the pharmacological properties of 3-cyano-10-(3-dimethylamino-2-methylpropyl)-phenothiazine or cyamepromazine (R.P. 7.204)]. JULOU L; DUCROT R; FOURNEL J; LEAUO ; BARDONE MC; MYON J C R Seances Soc Biol Fil; 1961; 155():1029-34. PubMed ID: 14452776 [No Abstract] [Full Text] [Related]
6. [Phenothiazine drugs as photosensitizers and photoprotectors]. Makareeva EN; Lozovskaia EL; Sapezhinskiĭ II Biofizika; 1998; 43(2):181-5. PubMed ID: 9591093 [TBL] [Abstract][Full Text] [Related]
7. A new drug for control of itching--trimeprazine [1(o)-(3-dimethylamino-2-methylpropyl)-phenothiazine]. HUDSON AL Can Med Assoc J; 1959 Jan; 80(2):125. PubMed ID: 13618809 [No Abstract] [Full Text] [Related]
8. [Pharmacological study of a new neuroplegic drug: 8-acetyl-10-(3-dimethylaminopropyl) phenothiazine maleate (CB 1522). II. Effect on the cardiovascular & autonomic nervous systems; various types of action; deductions]. MERCIER J; SCHMITT J; NAVARRO J; GAVEND MR; GAVEND M Arch Int Pharmacodyn Ther; 1958 Jan; 113(3-4):336-59. PubMed ID: 13522273 [No Abstract] [Full Text] [Related]
9. [Utilization of the neuroplegic properties of chloro-3-(dimethylamino-3'-propyl)-10-phenothiazine hydrochloride (R.P. 4560) in neuropsychiatric therapy]. SIGWALD J; BOUTTIER D Presse Med (1893); 1953 Apr; 61(29):607-9. PubMed ID: 13074090 [No Abstract] [Full Text] [Related]
10. The primary in vitro anticancer activity of "half-mustard type" phenothiazines in NCI's revised anticancer screening paradigm. Wuonola MA; Palfreyman MG; Motohashi N; Kawase M; Gabay S; Gupta RR; Molnár J Anticancer Res; 1998; 18(1A):337-48. PubMed ID: 9568100 [TBL] [Abstract][Full Text] [Related]
11. [Experience in the therapy of schizophrenic psychoses with the phenothiazine derivative imiclopazine under the criterion for the neuroleptic threshold]. Haase HJ; Linden KJ; Boragk J Med Welt; 1969 Jul; 28():1565-70. PubMed ID: 5810234 [No Abstract] [Full Text] [Related]
12. [Pharmacological study of a new phenothiazine derivative: perphenazine]. ARRIGONI-MARTELLI E; KRAMER M Arch Int Pharmacodyn Ther; 1959 Apr; 119(3-4):311-33. PubMed ID: 13650723 [No Abstract] [Full Text] [Related]
13. [Activity of a new phenothiazine in psychiatry and neurology; therapeutic properties of 10-(3-dimethylamino-2-methyl-propyl)-3-methoxyphenothiazine]. BOUTTIER D; HENNE M; QUETIN A; RAYMONDEAUD C; SIGWALD J Presse Med (1893); 1956 Dec; 64(87):2011-4. PubMed ID: 13389375 [No Abstract] [Full Text] [Related]
14. Cytotoxicity and differentiation-inducing activity of phenothiazine and benzo[a]phenothiazine derivatives. Motohashi N; Sakagami H; Kamata K; Yamamoto Y Anticancer Res; 1991; 11(5):1933-7. PubMed ID: 1662929 [TBL] [Abstract][Full Text] [Related]
15. [Pharmacological properties of the new neuroleptic of the phenothiazine series--dixyrazine]. Mikhaĭlova TV; Terekhina AI; Gilev AP Farmakol Toksikol; 1969; 32(1):28-31. PubMed ID: 4388895 [No Abstract] [Full Text] [Related]
16. Neither lipophilicity nor membrane-perturbing potency of phenothiazine maleates correlate with the ability to inhibit P-glycoprotein transport activity. Hendrich AB; Wesołowska O; Poła A; Motohashi N; Molnár J; Michalak K Mol Membr Biol; 2003; 20(1):53-60. PubMed ID: 12745926 [TBL] [Abstract][Full Text] [Related]
18. [Pharmacological study of a new neuroplegic; 8-acetyl-10-(3-dimethylaminopropyl) phenothiazine maleate: CB-1522. I. Toxicity: effects on the central & peripheral nervous systems]. MERCIER J; SCHMITT J; AUROUSSAEU M; ETZENSPERGER P; BONIFAY D Arch Int Pharmacodyn Ther; 1957 Dec; 113(1-2):53-75. PubMed ID: 13509771 [No Abstract] [Full Text] [Related]
19. [Activity of a new piperidinic phenothiazine in clinical psychiatry: 3-methoxy-10-(3-(4"-hydroxypiperidine)-2-methylpropyl)-phenothiazine]. Delay J; Deniker P; Lemperiere T; Ginestet D Therapie; 1969; 24(3):509-12. PubMed ID: 5399542 [No Abstract] [Full Text] [Related]
20. [New derivative of phenothiazine of psychic & neurovegetative action: dimethylamino-n-propylphenothiazine (promazine)]. CASTELLUCCIO R Dia Med; 1959 Jun; 31(35):934. PubMed ID: 13672027 [No Abstract] [Full Text] [Related] [Next] [New Search]